Evidence map›Paper›PMID 28178207›Full record

ArticleJournal of clinical medicine2017

Impact of Cannabis Use on Treatment Outcomes among Adults Receiving Cognitive-Behavioral Treatment for PTSD and Substance Use Disorders.

Lesia M Ruglass, Alina Shevorykin, Vanja Radoncic, Kathryn M Z Smith, Philip H Smith, Isaac R Galatzer-Levy, Santiago Papini, Denise A Hien

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Impact of self-reported cannabis use on veterans' intensive PTSD treatment outcomes.Psychological trauma : theory, research, practice and policy · 2026
    Article
  4. Article
  5. Observational
  6. Review
  7. Cannabis industry and medical cannabis clinics need regulation.Canadian family physician Medecin de famille canadien · 2019
    Article
  8. Canadian family physician Medecin de famille canadien · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 1 country.

Lesia M RuglassDepartment of Psychology, The City College of New York, CUNY, 160 Convent Avenue, NAC Building, Rm 7/120, New York, NY 10031, USA. ruglass.ccny@gmail.com.
Alina ShevorykinDepartment of Psychology, Pace University, 861 Bedford Road, Pleasantville, NY 10570, USA. alina.shevorykin@gmail.com.
Vanja RadoncicGordon F. Derner Institute for Advanced Psychological Studies, Adelphi University, IAPS, Hy Weinberg Center, Room 306, Garden City, NY 11530-0701, USA. vanyaradoncic@gmail.com.
Kathryn M Z SmithDivision on Substance Use Disorders, Department of Psychiatry, Columbia University Medical Center/New York State Psychiatric Institute, 1051 Riverside Drive, Box 66, New York, NY 10032, USA. k.m.zumberg@gmail.com.
Philip H SmithSophie Davis School of Biomedical Education, The City College of New York, 160 Convent Avenue, New York, NY 10031, USA. psmith@med.cuny.edu.
Isaac R Galatzer-LevyDepartment of Psychiatry, NYU School of Medicine, 1 Park Avenue, New York, NY 10016, USA. isaac.galatzer-levy@nyumc.org.
Santiago PapiniDepartment of Psychology and Institute for Mental Health Research, University of Texas, Austin, 108 E. Dean Keeton Street, Austin, TX 78712, USA. papinisan@gmail.com.
Denise A HienGordon F. Derner Institute for Advanced Psychological Studies, Adelphi University & Department of Psychiatry, Columbia University College of Physicians and Surgeons, Hy Weinberg Center, Room 306, Garden City, NY 11530-0701, USA. dr.denise.hien@gmail.com.
City College of New York · USAdelphi University · USColumbia University · USNew York Psychoanalytic Society and Institute · USNew York University · USPace University · US

Funding

Translational Clinical Research Fellowship on Substance Use DisordersT32DA007294 · NIDA · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Frances Rudnick Levin, Diana M Martinez · 1993 to 2026
$9.3M
Combined Treatment of Alcohol-Dependent Women with PTSDR01AA014341 · NIAAA · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI HIEN, DENISE AIMEE · 2005 to 2009
$3.2M
NIAAA NIH HHS R01 AA014341NIDA NIH HHS T32 DA007294
6 · The paper itself

Abstract

backgroundResearch has demonstrated a strong link between trauma, posttraumatic stress disorder PTSD and substance use disorders (SUDs) in general and cannabis use disorders in particular. Yet, few studies have examined the impact of cannabis use on treatment outcomes for individuals with co-occurring PTSD and SUDs.

methodsParticipants were 136 individuals who received cognitive-behavioral therapies for co-occurring PTSD and SUD. Multivariate regressions were utilized to examine the associations between baseline cannabis use and end-of-treatment outcomes. Multilevel linear growth models were fit to the data to examine the cross-lagged associations between weekly cannabis use and weekly PTSD symptom severity and primary substance use during treatment.

resultsThere were no significant positive nor negative associations between baseline cannabis use and end-of-treatment PTSD symptom severity and days of primary substance use. Cross-lagged models revealed that as cannabis use increased, subsequent primary substance use decreased and vice versa. Moreover, results revealed a crossover lagged effect, whereby higher cannabis use was associated with greater PTSD symptom severity early in treatment, but lower weekly PTSD symptom severity later in treatment.

conclusionCannabis use was not associated with adverse outcomes in end-of-treatment PTSD and primary substance use, suggesting independent pathways of change. The theoretical and clinical implications of the reciprocal associations between weekly cannabis use and subsequent PTSD and primary substance use symptoms during treatment are discussed.

Indexed as

cannabisPTSDsubstance use disordertraumatreatment outcomes

Identifiers

PMID28178207
PMCPMC5332918
OpenAlexW2586544687

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.